Cargando…

Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes

BACKGROUND: Maternal malaria is a tropical scourge associated with poor pregnancy outcomes. Women become resistant to Plasmodium falciparum pregnancy malaria as they acquire antibodies to the variant surface antigen VAR2CSA, a leading vaccine candidate. Because malaria infection may increase VAR2CSA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fried, Michal, Kurtis, Jonathan D., Swihart, Bruce, Morrison, Robert, Pond-Tor, Sunthorn, Barry, Amadou, Sidibe, Youssoufa, Keita, Sekouba, Mahamar, Almahamoudou, Andemel, Naissem, Attaher, Oumar, Dembele, Adama B., Cisse, Kadidia B., Diarra, Bacary S., Kanoute, Moussa B., Narum, David L., Dicko, Alassane, Duffy, Patrick E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845157/ https://www.ncbi.nlm.nih.gov/pubmed/29523137 http://dx.doi.org/10.1186/s12936-018-2258-9

Ejemplares similares

Host factors that modify Plasmodium falciparum adhesion to endothelial receptors
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Age-dependent increase in antibodies that inhibit Plasmodium falciparum adhesion to a subset of endothelial receptors
por: Attaher, Oumar, et al.
Publicado: (2019)

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali
por: Andemel, Naissem, et al.
Publicado: (2020)

Antibody Levels to Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLγ11 and DBLδ-1 Predict Reduction in Parasite Density
por: Araj, Brittany N., et al.
Publicado: (2021)

Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2021)

Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2022)

A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
por: Doritchamou, Justin YA, et al.
Publicado: (2022)

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
por: Gaoussou, Santara, et al.
Publicado: (2022)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
por: Dicko, Alassane, et al.
Publicado: (2015)

IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2021)

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
por: Stone, Will, et al.
Publicado: (2022)

Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
por: Oulton, Tate, et al.
Publicado: (2022)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio
por: Bradley, John, et al.
Publicado: (2019)

Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial
por: Stone, William, et al.
Publicado: (2022)

NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
por: Chmielewska, Sylwia Joanna, et al.
Publicado: (2020)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Maintainence of parasitaemia – is it to die for?
por: Tyler, Kevin M
Publicado: (2003)

Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, Mali
por: Vanheer, Leen N., et al.
Publicado: (2023)

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa
por: Woodford, John, et al.
Publicado: (2022)

Malaria Morbidity in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria in Mali: A Randomized Control Trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris
por: Avril, Marion, et al.
Publicado: (2009)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
por: Diawara, Fatou, et al.
Publicado: (2017)

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)

Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
por: Dicko, Alassane, et al.
Publicado: (2018)

Note of a Case of Retroversion of the Gravid Uterus
por: Buist, J. B.
Publicado: (1878)

Retroflexion of the Gravid Uterus
Publicado: (1900)

Injury of the Gravid Uterus
Publicado: (1927)

Wound of Gravid Uterus
por: Standage, R. F.
Publicado: (1905)

Retroversion of the Gravid Uterus
Publicado: (1908)

Retroversion of Gravid Uterus
por: Buist,
Publicado: (1878)

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01(E) vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
por: Chandramohan, Daniel, et al.
Publicado: (2020)

Effect of Solanum Nigrun on Uterus of Non-gravid Rats
por: Agoreyo, Freddy O, et al.
Publicado: (2017)

Gravid Uterus in an Umbilical Hernia
por: Mbuagbaw, Lawrence C. E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ii531en15fgit70m32th452b30